Healthcare research company expands into Barnsley

Healthcare research company expands into Barnsley

The UK’s largest neuroscience research company is set to create 12 new jobs when it opens a new research site in Barnsley this month.

MAC Clinical Research, which has sites in Manchester, Leeds, Blackpool, Cannock and Liverpool, is set to move to 4,800 sq ft office space at Wentworth Office Park in Tankersley.

The company specialises in clinical trials in therapeutic areas including Alzheimer’s disease, diabetes, osteoarthritis, eczema, psoriasis, central nervous system conditions and depression. As well as conducting the trials, MAC Clinical Research recruit volunteers to take part in them.

MAC Clinical Research currently employs 150 people across its six research sites. £500,000 has been invested into the former office space, providing suitable working environments for clinical trials to take place.

The research company has been supported by Enterprising Barnsley, the business development arm of Barnsley Council.

Chief executive officer of MAC Clinical Research, Dr Mark Dale, said: “The move into Barnsley is a natural expansion for us and will see us get more heavily involved in the South Yorkshire market. In the not too distant future, we’re looking to open up more research sites across Yorkshire.”

One of the first trials at the new Barnsley clinic is into osteoarthritis and will see the company work with doctors in the local community to identify suitable volunteers.

Dr Victoria Lynch, clinical research physician of the Barnsley clinic, said: “We are excited to be currently trialling a new pain medication for osteoarthritis of the knee involving patients aged between 50 to 75 years. Previous trials have shown very positive results and we are hopeful that patients will be interested to participate.”

MAC Clinical Research started life in 1988 as a memory assessment centre before moving into clinical research trials in 2003. In 2007, the company opened its first purpose-built dedicated research centre in Blackpool, followed a year later by one in Manchester. In 2011, the company opened a research facility in the midlands, meaning that 20 million people lived within one hour of a MAC clinic.

MAC Clinical Research has a range of clinical research capabilities to accommodate early phase trials through to market approval.

Martin Beasley, Enterprising Barnsley Group Leader, said: “We’re delighted to welcome the company to Barnsley.

“MAC Clinical Research is now starting to get the staff in place to become fully operational. We wish them all the best and look forward to working with them in the future.”

Enterprising  Barnsley, the business development arm of Barnsley Council, provides specialist support to businesses with growth potential.


Notes to editor

Attached photograph shows the new MAC PLC site in Barnsley.

For more information about MAC PLC go to or contact Nathan Berry on 07821 068599.

For further information about Enterprising Barnsley, please contact Martin Beasley on 01226 787535 or visit

Enterprising Barnsley, part of Barnsley Council, assists companies with relocation; business development; access to finance; business start-up and much more. Its award-winning team provides a practical link between business owners and a wide range of resources and support available to them in Barnsley. It can help businesses access specialist coaching. It also funds and delivers a range of business events and workshops. EB’s aim is to help Barnsley businesses develop and expand; generating economic growth and creating jobs.

Additional media contact: Joshua Nutt 01226 766900 or at

Sign up to receive our newsletter.

Keep up to date with news and information from Enterprising Barnsley.
* indicates required

Please select all the ways you would like to hear from Enterprising Barnsley:

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.